Inventor · disambiguated record
Elizabeth Mary Beck
Also filed as: BECK ELIZABETH MARY
26 granted patents·13 pending applications·201 citations·filing 2013–2025
96Inventor score
Top patents by PatentIndex Score
39 records- 0195US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 0295US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 0394US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 0494US9315520B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2015·Granted Apr 19, 2016·15 cites·26 claims
- 0594US9198917B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2015·Granted Dec 1, 2015·14 cites·21 claims
- 0694US8822456B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Sep 2, 2014·19 cites·11 claims
- 0793US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 0893US9428523B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2016·Granted Aug 30, 2016·12 cites·37 claims
- 0993US9192612B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2015·Granted Nov 24, 2015·13 cites·17 claims
- 1093US9045498B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jun 2, 2015·18 cites·17 claims
- 1193US9045499B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jun 2, 2015·17 cites·7 claims
- 1293US8865706B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Oct 21, 2014·19 cites·9 claims
- 1392US8962616B2Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Feb 24, 2015·18 cites·18 claims
- 1491US9605007B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2016·Granted Mar 28, 2017·8 cites·6 claims
- 1590US9845301B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2016·Granted Dec 19, 2017·8 cites·9 claims
- 1689US10604519B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2017·Granted Mar 31, 2020·3 cites·24 claims
- 1789US9233981B1Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jan 12, 2016·12 cites·17 claims
- 1885US10028962B22-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2017·Granted Jul 24, 2018·3 cites·40 claims
- 1985US9260455B2Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Feb 16, 2016·7 cites·13 claims
- 2085US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2183US2024190869A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 2282US10428034B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2017·Granted Oct 1, 2019·3 cites·18 claims
- 2382US9744173B22-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2017·Granted Aug 29, 2017·2 cites·24 claims
- 2481US2023192690A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 2580US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 2677US11905284B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2021·Granted Feb 20, 2024·0 cites·18 claims
- 2769US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 2868US2020207762A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2020·Application pending·0 cites
- 2966US10723711B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2019·Granted Jul 28, 2020·0 cites·18 claims
- 3062US2023382910A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3160US2025388541A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3260US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3359US12503439B2Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Granted Dec 23, 2025·0 cites·35 claims
- 3458US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3558US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3658US2025388543A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3757US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3843US11198692B2Dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2018·Granted Dec 14, 2021·0 cites·21 claims
- 3942US2015133438A1Heterocyclic Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine CompoundsPFIZER·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →